Speckle-tracking echocardiography has enabled clinicians to detect changes in myocardial function with more sensitivity than that afforded by traditional diastolic and systolic functional measurements, including left ventricular ejection fraction. Speckle-tracking echocardiography enables evaluation of myocardial strain in terms of strain (percent change in length of a myocardial segment relative to its length at baseline) and strain rate (strain per unit of time). Both measurements have potential for use in diagnosing and monitoring the cardiovascular side effects of cancer therapy. Regional and global strain measurements can independently predict outcomes not only in patients who experience cardiovascular complications of cancer and cancer therapy, but also in patients with a variety of other clinical conditions. This review and case series examine the clinical applications and overall usefulness of speckle-tracking echocardiography in cardio-oncology and, more broadly, in clinical cardiology.
Noninvasive imaging plays a crucial role in the prevention, diagnosis, and treatment of cardiovascular disease in both cancer patients and cancer survivors. Among the different noninvasive imaging methods available, echocardiography is inexpensive, widely available, and radiation-free; moreover, during the last decade, temporal resolution has greatly improved. Therefore, it is considered the test of choice for evaluating heart disease and, now, mechanical function.
Cardiac mechanics integrate the diverse elastic and contractile forces of cardiac myocytes. Cardiac sarcomere structures have 3 different spatial orientations: longitudinal, radial, and circumferential. This arrangement enables efficient myocardial contraction, characterized by shortening, thickening, and twisting of the myocardium, which can be likened to wringing out a wet towel.1 Whereas conventional echocardiography captures the thickening motion of radially oriented myocardial fibers, it cannot accurately show the shortening and twisting motions of longitudinally and circumferentially oriented fibers. Consequently, conventional echocardiography cannot fully differentiate between active and passive myocardial movement.2
Both STE and TDI can provide global estimates of left ventricular (LV) mechanics as well as information about the 3 spatial dimensions of cardiac deformation.5 Unlike TDI, however, STE exploits the multiple bright speckles that are produced by the reflection, refraction, and scattering of ultrasound beams and captured on a normal echocardiogram. Software for STE, regardless of vendor, can generate information on myocardial deformation by tracking these speckles frame-to-frame throughout the cardiac cycle. Speckle-tracking echocardiography is also angle-independent and thus less prone to intra- and interobserver variability.6 Meta-analyses suggest that the mean normal strain values derived by STE are −19.7% (95% CI, −18.9% to −20.4%) for global longitudinal strain (GLS), −23.3% (95% CI, −22.1% to −24.6%) for global circumferential strain (GCS), and 47.3% (95% CI, 43.6% to 51%) for global radial strain (GRS); note, however, that each STE software vendor will report its own suggested normal values.7,8 A 2014 meta-analysis that included 5,721 patients with diverse cardiovascular diseases revealed that STE-derived GLS was better than LVEF at predicting all-cause mortality and major adverse cardiac events.9
During the last few decades, continued advances in cancer therapeutics have greatly improved the overall survival rate in cancer patients.10 However, many agents have cardiotoxic side effects that can manifest themselves early or even years after treatment. These side effects depend not only on the chemotherapeutic drug and dosage used but also on the susceptibility of individual patients. Because a large number of cancer patients who experience a decrease in LVEF will not recover full cardiac function without early diagnosis and therapy, the use of STE has important clinical implications.11–13 Speckle-tracking echocardiography can detect myocardial dysfunction before a decrease in LVEF and enables clinicians to predict which patients will eventually develop chemotherapy-related cardiac dysfunction (CRCD).14,15
Trastuzumab and anthracyclines are the 2 best-characterized drugs associated with CRCD. In patients with breast cancer who receive both, a >10% decrease in peak GLS and a decrease in radial strain measured by STE predict a symptom-associated decrease in LVEF within the next 3 to 6 months.14,16,17 In a systematic review that included 1,504 cancer patients undergoing diverse chemotherapy regimens based on anthracyclines, trastuzumab, or both, STE was found to be prognostically superior to TDI.18 The investigators for that review also demonstrated that a relative decline in GLS of 10% to 15% was a useful predictor of CRCD.18 Another study in cancer patients who were treated with anthracycline-based regimens analyzed a torsional subepicardial LV deformation parameter denoted by LV twist.13 The product of LV twist and GLS 6 weeks after chemotherapy was the best predictor of subsequent CRCD, followed by GLS alone.13 Finally, in a small observational study that included 52 patients who had received trastuzumab, anthracyclines, or both and then experienced a ≥11% drop in GLS, β-blocker treatment was associated with a significant improvement (P <0.001) in STE-derived GLS and LVEF.19 Only 14 patients in this group had a decrease in LVEF consistent with CRCD.19 Consequently, myocardial deformation could help identify patients with early LV dysfunction.
This review will now focus on the clinical application of STE to various cardio-oncologic diseases and then present specific cases illustrating its use to detect and recognize typical patterns of GLS seen on STE-derived polar (or “bull's-eye”) maps in cancer patients.
Radiation-Induced Heart Disease
Radiation therapy (RT), either alone or in combination with other cancer therapies, has played a vital role in improving the survival of patients with thoracic malignancies such as breast cancer and Hodgkin lymphoma. However, exposing the cardiac field to radiation can injure cardiac structures, leading to coronary artery disease (CAD), cardiomyopathy, conduction abnormalities, valvulopathies, and pericardial disease.20 Even a minimal dose of radiation increases the rate of heart disease. Each gray (Gy) increase in radiation is associated with a 7.4% increase in the incidence of ischemic heart disease, and this increased risk typically becomes apparent within the first 5 years after exposure and persists for at least 2 decades.21
The pathogenesis of radiation-induced heart disease involves diverse microvascular changes. Endothelial cells become more permeable, followed by neutrophil migration into the interstitial space, increased reactive oxygen species formation, DNA damage, inflammation, and eventually fibrosis.22 The damage to affected coronary arteries is related to the maximal radiation dose distribution. Both the left anterior descending coronary artery (LAD) and right coronary artery (RCA) are primarily affected in patients receiving mantle field radiation. Radiation of left- and right-sided breast cancer tends to affect the mid-LAD and proximal RCA, respectively. Arterial stenosis caused by RT usually affects the coronary ostia.23–26 Although not yet clinically tested for its diagnostic usefulness in patients with radiation-induced CAD, STE has proved diagnostically useful in patients with stable angina and normal LVEF. A decrease in regional longitudinal systolic strain can help identify the culprit coronary artery. In addition, GLS measured at rest enhances the diagnostic performance of exercise stress testing.27
Myocardial damage is another frequent complication of RT that can become apparent soon or several years after treatment. In one study of acute RT-induced cardiac dysfunction, women with left-sided breast cancer who received adjuvant RT experienced a decrease in GLS and strain rate that persisted for up to 6 weeks after completing treatment.28 However, no changes in LVEF were observed during that time.28 The changes in myocardial deformation appear to be dose-dependent. In another study, the largest decrease in regional strain was seen in the apical peak systolic strain and strain rate, measurements corresponding with the segment of the heart (in this case, the apex) subject to the highest radiation dose.29 However, no concise dose-volume relationship for RT-induced cardiac dysfunction has yet been determined.30 In a study of long-term Hodgkin lymphoma survivors who received mediastinal RT with or without anthracyclines, STE was used to look at cardiac mechanics 2 decades after successful treatment. Global longitudinal strain was lower in patients who received RT plus anthracyclines (−16.1% ± 1.9%) or RT alone (−17.5% ± 1.7%) than in healthy control subjects (−20.4% ± 1.7%). Thus, RT combined with anthracyclines had an additional negative long-term effect on cardiac mechanics.31 A more recent meta-analysis in cancer survivors confirmed that thoracic RT was associated with increased risk of heart failure at least 5 years after treatment.32 The hazard ratios reported were 2.7 to 7.4 for Hodgkin lymphoma and 1.5 to 2.4 for breast cancer.32 In prospective studies under way, investigators are using STE, among other noninvasive and invasive imaging methods, and a wide range of biomarkers to elucidate the effects and mechanisms of RT-induced heart disease.33
Infiltrative cardiomyopathies are rare, difficult to diagnose, associated with poor outcomes, and late-occurring in the clinical course of systemic illness. They are all characterized by the abnormal deposition of substances in the myocardial cells or the intercellular matrix of the myocardium, which, if left unchecked, can lead to heart failure and even restrictive cardiac physiology. Infiltrative cardiomyopathies frequently seen in oncologic patients are cardiac amyloidosis, iron-overload cardiomyopathy (IOC), and lymphomatous involvement of the myocardium. Speckle-tracking echocardiography has proved useful in the diagnosis and prognosis of infiltrative cardiomyopathies.
Cardiac amyloidosis is the infiltrative cardiomyopathy seen most often in cardio-oncology. A systemic disease usually diagnosed later in life,34,35 amyloidosis is caused by the extracellular deposition of misfolded β-pleated fibrils, leading to tissue and organ damage.36 The 2 most common types are transthyretin amyloidosis (ATTR) and immunoglobulin light-chain amyloidosis (AL). The transthyretin type often affects the elderly and in most cases involves only the heart.
Iron-overload cardiomyopathy occurs most often in cancer patients with bone marrow infiltration or hema tologic malignancies who require recurrent blood transfusions, although it is classically associated with hemochromatosis.37 Chronic systemic iron overload eventually leads to the deposition of iron in the myocardium and subsequent reactive oxygen species formation, mitochondrial damage, and cardiomyocyte death.38 Lymphomatous myocardial involvement is seen at autopsy in 16% of patients with Hodgkin lymphoma and 18% of patients with non-Hodgkin lymphoma. Cardiac compromise occurs at a median of 20 months after initial lymphoma diagnosis.39 Previous studies in patients with IOC secondary to thalassemia major revealed a significant reduction in GCS, GRS, and global end-systolic rotation. These abnormalities in myocardial deformation were seen despite a normal T2 score >20 ms on cardiac magnetic resonance imaging scans, consistent with normal or minimal iron deposition.40,41 These findings suggest that myocardial iron overload is not the only mechanism underlying IOC, although it does play a central role in its development.42
A worsening of longitudinal strain in IOC patients is the only independent predictor of adverse clinical events and death.43 In both AL and ATTR, left ventricular GLS (LVGLS) is significantly reduced along the basal-to-apical gradient. Regional longitudinal strain is reduced mostly in the basal wall regions with apical sparing, leading to the typical “polar map” plot seen in color-coded LV strain displays.44,45 Reduced GLS is an independent predictor of survival in AL, and a decline in apical longitudinal strain is an independent predictor of major cardiovascular events in both AL and ATTR.46,47
Valvular Heart Disease
The association between RT and valvular heart disease (VHD) has been well documented since the 1960s.48 Multiple studies have shown an increased rate of VHD after thoracic RT.24,49,50 Asymptomatic Hodgkin lymphoma survivors who received mediastinal RT were found to have VHD in 32% of cases at 6 years and 42% at 20 years.51,52 As in the case of RT-induced CAD, the risk of VHD increases with higher radiation doses. In one study, for radiation doses of 30, 31–35, 36–40, and >40 Gy to a given valve, the approximate 30-year cumulative risk of VHD was 3%, 6.4%, 9.3%, and 12.4%, respectively.53 Despite providing evidence that anthracyclines increased the risk of valvulopathy, most of the studies cited above did not reveal the type or severity of valvular dysfunction. Therefore, it was not possible to distinguish intrinsic valvular pathology from mitral regurgitation in the presence of anthracycline-induced cardiomyopathy.54,55 This issue was addressed, however, by a cross-sectional study of lymphoma survivors who received high-dose anthracyclines with and without RT. In that study, the incidence of valvular disease (usually aortic valve degeneration) was greater in the chemotherapy- only group than in a healthy age- and sex-matched control group (14% vs 4%, P =0.002).56
Over the last few years, various studies have proved the usefulness of STE in predicting outcomes in patients with VHD and their need for early surgical referral. In asymptomatic patients with chronic severe primary mitral regurgitation, LVEF is the main determinant of surgical intervention. Current guidelines recommend surgery in this patient population when there is evidence of LV dysfunction, defined as an LVEF between 0.30 and 0.60 or an LV end-systolic diameter ≥40 mm (class I, level of evidence B).57,58 Despite early intervention, however, postoperative LV dysfunction still occurs. In one study, a GLS greater than −19.9% on STE was a major independent predictor of postoperative LV dysfunction in asymptomatic patients with chronic severe primary mitral regurgitation.59 In another study, LVGLS was greater in patients who had severe mitral regurgitation but no significant LV dilation or dysfunction than it was in control subjects because of the left ventricle's hyperdynamic function during regurgitation.60
Left ventricular GLS measured by STE has also been shown to be important in the risk stratification of patients with moderate-to-severe primary mitral regurgitation and normal LVEF. In these patients, the absence of LV contractile reserve, defined as a >2% improvement in GLS during peak exercise, was associated with a 2-fold increase in risk of cardiac events.61 In patients with asymptomatic severe aortic regurgitation, surgery is reasonable when the LVEF is ≥0.50 with severe LV dilation with an LV end-systolic dimension >5 cm or an indexed LV end-systolic diameter >2.5 cm/m2 (class IIa, level of evidence B).57,58 In a study of patients with chronic severe aortic regurgitation, preserved LVEF, and nondilated ventricles (LV end-systolic diameter index, <2.5 cm/m2), a decrease in LVGLS was significantly associated with increased long-term mortality (P <0.001), proving its prognostic value in this clinical situation.62 In asymptomatic patients with chronic severe aortic stenosis and normal LVEF, GLS can independently predict mortality and the need for aortic valve replacement.63,64 Although none of the VHD studies reviewed in this section included cancer patients or survivors, we think that the concepts described are also applicable to patients with cancer therapeutics–related VHD.
Pericardial diseases are often seen in cardio-oncology practice. Involvement of the pericardium can manifest itself in a spectrum of syndromes, including pericarditis, pericardial effusion, tamponade, and constrictive pericarditis; and it usually has a major impact on overall outcomes. One study showed that pericarditis may be a marker of occult cancer and that it may predict increased risk of death after a cancer diagnosis.65 Pericardial tumors, which are rarely primary, often result from metastatic lung and brain cancer, melanoma, and lymphoma. They are usually accompanied by recurrent pericardial effusions or tamponade and associated with a poor prognosis.
Both RT and diverse chemotherapeutic agents can cause pericardial disease.66 Radiation-induced pericardial disease can manifest itself as pericarditis, pericardial effusion, delayed thickening, and constrictive pericarditis. Pericarditis can develop acutely after mediastinal irradiation at a dose >40 Gy.67 Pericardial effusions are usually diagnosed months or years after mediastinal RT, and these fibrinous exudates are often loculated.22,68 Constrictive pericarditis presents as newly diagnosed congestive heart failure approximately 10 years after RT.69
Speckle-tracking echocardiography plays an important role in differentiating between constrictive pericarditis and restrictive cardiomyopathy. In patients with constrictive pericarditis, the circumferential strain, torsion, and early diastolic apical untwisting velocities are markedly reduced. In contrast, in patients with restrictive cardiomyopathy, the longitudinal strain is reduced.70,71 In addition, detailed echocardiographic analysis of 3-layer longitudinal and circumferential strain and twist angle shows promise for helping to distinguish between various perimyocardial inflammatory syndromes, ranging from predominantly pericarditis to predominantly myocarditis.72
Various aspects of strain imaging provide information about cardiac mechanics and myocardial function. Ensuring that the myocardium is well traced on 2-dimensional images so that only myocardial—as opposed to pericardial—speckles are being tracked helps validate the strain data obtained in each particular study. Viewing the strain curves as a function of time and in comparison with the electrocardiogram (ECG) signal provides data about myocardial function throughout the cardiac cycle. However, evaluating all of these data in addition to interpreting the rest of a conventional echocardiogram takes considerable time, which may not be available in busy cardiology practices. A time-saving, beneficial alternative involves recognizing patterns of peak systolic strain on 17-segment polar maps, similar to interpreting the polar map of a myocardial perfusion study. In the medical literature and in clinical practice, longitudinal strain—as opposed to circumferential or radial strain—is the most frequently analyzed strain parameter.
In each of the following case reports, a distinctive polar map of GLS peak systolic strain derived by STE is presented, along with a narrative from the clinician's perspective. In each polar map, a dark red pattern indicates normal function; a lighter red or pink pattern, dysfunction; and a blue pattern, the worst dysfunction.
Normal Pattern. A 64-year-old man presented with shortness of breath that had persisted for several weeks and worsened over the previous 3 days. The patient's medical history included parotid gland stage IV carcinoma, dyslipidemia, and hypertension; 3 years previously, he had undergone percutaneous coronary intervention (PCI) with a drug-eluting stent to treat CAD in the distal LAD. Clinical and laboratory evaluations revealed pneumonitis, pneumonia, and a mildly elevated troponin I level. Aspirin and ticagrelor that the patient had been taking were discontinued by his oncologist because of chronic thrombocytopenia. An echocardiogram showed an LVEF of 0.61 and a normal strain pattern (Fig. 1), supporting the clinician's suspicion of a noncoronary cause for the current abnormal troponin I biomarker findings. Over the next month, the patient's pulmonary issues responded appropriately to medical therapy, and he had no further cardiac issues.
The homogeneously red polar map (Fig. 1) indicated a normal longitudinal strain pattern in this patient. Used as a reference, this map highlights the glaring abnormalities in strain pattern seen on the polar maps in the following cases.
Three-Vessel Coronary Artery Disease. A 72-year-old man with ischemic cardiomyopathy, an LVEF of 0.30 to 0.35, and peripheral vascular disease presented with shortness of breath and coughing. The patient's medical history included transient ischemic attack, dyslipidemia, chronic obstructive pulmonary disease, carotid stenosis, squamous cell carcinoma and presumed primary lung tumor treated with chemotherapy and radiation (completed 2 years previously), and ongoing cardiologic monitoring for CAD. Cardiac catheterization 4 years before presentation had revealed a patent LAD, 50% stenosis in the RCA, and an occluded left circumflex coronary artery (LCx) with right-to-left collateral vessels. Cardiac positron emission tomograms at presentation showed an LVEF of 0.34 with inferior and inferolateral hypokinesis.
This patient's longitudinal strain polar map (Fig. 2) revealed a pattern of segmental dysfunction that matched the known coronary anatomy. The pink pattern indicated dysfunction in the RCA and LCx territories; the red band through the anteroseptal and apical wall segments indicated relative sparing of the LAD territory.
Single-Vessel Left Anterior Descending Coronary Artery Disease. A 48-year-old man with non-small cell lung cancer presented with chest pain. An ECG showed ST-segment elevations in the inferior leads and a QS pattern in the anterior leads. Cardiac enzyme levels were elevated. An echocardiogram showed hypokinesis of the inferior, anterior, and apical segments and an LVEF of 0.35 to 0.40. Emergency coronary angiograms revealed LAD occlusion with fresh thrombus, so PCI with bare-metal stenting was performed.
This patient's longitudinal strain polar map (Fig. 3) revealed defects in the LAD territory, as indicated by pink in the basal-to-mid segments and blue in the apical segments, whereas the rest of the polar map was homogeneously red. This pattern fits with a proximal-to-mid-LAD vessel occlusion causing substantial myocardial dysfunction distally in the vessel's territory, concordant with the angiographic findings in this case.
Single-Vessel Right Coronary Artery Disease. A 71-year-old man presented for prostatectomy. His medical history included basal cell carcinoma of the neck treated by resection 6 years previously and revision one year previously, prostate cancer, and CAD treated by remote angioplasty of the proximal RCA. The patient had been regularly evaluated by a local cardiologist, and his most recent nuclear stress test results showed no evidence of ischemia. The patient reported no symptoms of chest discomfort or palpitations. He had been relatively active, including walking 2 miles daily and using a push lawnmower without difficulty. An echocardiogram showed an LVEF of 0.45 to 0.50 and mild hypokinesis of the inferior wall.
This patient's polar map (Fig. 4), although slightly more subtle than a typical polar map in its depiction of the myocardial defect in pink rather than blue, showed a pink-to-light red pattern in the basal-to-mid segments of the RCA territory, as opposed to the deeper red pattern in other segments. This finding suggests residual myocardial dysfunction in the RCA territory after the angioplasty, as corroborated by the inferior-wall hypokinesis seen echocardiographically. Of note, a nuclear stress test revealed normal perfusion and function, apparently missing the myocardial dysfunction seen on echocardiograms.
Single-Vessel Left Circumflex Coronary Artery Disease. A 67-year-old man with a history of metastatic prostate cancer and skin cancer was admitted for resection of a recurrent leiomyosarcoma of the right parietal and frontal scalp. Postoperatively, the patient had an episode of hypotension marked by systolic blood pressure reaching a nadir of 70 mmHg, ECG changes (ST-segment depression in the anterior and lateral leads), and elevated cardiac enzyme levels. The patient reported no chest pain, dizziness, or shortness of breath, and he had no history of cardiac disease. An echocardiogram showed an LVEF of 0.45 to 0.50 and mild hypokinesis of the lateral wall. Coronary angiograms showed a calcified lesion with 85% stenosis in the ostial LCx.
This patient's polar map (Fig. 5) revealed a large area of dark blue distributed through the basal-to-mid segments of the posterolateral wall that correlated with the LCx stenosis seen on the angiograms. This alerted the clinician to a degree of dysfunction and myocardium at risk disproportionate to the relative mild dysfunction evidenced by the wall motion and LVEF alone.
Pseudo Left Circumflex Coronary Artery Disease. An 80-year-old woman presented with tachycardia and fatigue that had persisted for several weeks. Her medical history included left upper lobe adenocarcinoma treated by left upper lobectomy 11 years previously, CAD treated by PCI with 2 stents, and osteoporosis. A computed tomogram of the thorax revealed widespread metastatic disease in the supraclavicular, mediastinal, right mammary, and left hilar regions, and an apparent pericardial mass at the base of the lateral wall involving the pericardium and myocardium. An ECG showed sinus tachycardia with poor R-wave progression. An echocardiogram showed an LVEF of 0.60 to 0.65 and diffuse pericardial thickening.
This patient's polar map (Fig. 6A) revealed an abnormal pattern of LV peak systolic longitudinal strain at the location of infiltrative metastatic disease. The dark blue-to-pink pattern seen in the lateral and posterior wall segments of the map correlated with direct tumor infiltration of the myocardium, not with LCx stenosis as originally suspected. A chest computed tomogram (Fig. 6B) showed direct tumor infiltration of the myocardium at the basal lateral wall, correlating with the territory affected by the defect shown on the polar map.
Leukemic Infiltration Imitating Amyloidosis. A 13-year-old boy with acute lymphocytic leukemia (ALL) presented with back pain and was admitted with bacteremia. His medical history included double-cord stem cell transplantation 6 months previously, complicated by multiple infections, gastrointestinal graft-versus-host disease, malnutrition, and weight loss. The patient's condition deteriorated after admission, and he experienced respiratory distress. A chest radiograph showed cardiomegaly. An echocardiogram was obtained and, on STE analysis, revealed the strain pattern shown in Figure 7. Subsequently, the patient was found to have leukemic infiltration of the heart, which led to complete atrioventricular block necessitating implantation of a permanent pacemaker and heart failure management.
The typical polar map in patients with amyloidosis shows dark red distributed in the apical segments and light red-to-blue in the surrounding segments, indicative of apical sparing. In this case, that pattern represented ALL infiltrating the myocardium and mimicking the strain pattern of amyloidosis (Fig. 7). Therefore, we think apical preservation can be a pattern of nonspecific infiltration, not specific to amyloidosis.
Chemotherapy-Related Cardiotoxicity. A 59-year-old woman with a history of hypertension, breast cancer (treated with pertuzumab, trastuzumab, and docetaxel, completed 6 months previously), and syncope due to dehydration had been monitored for cardiotoxicity while receiving trastuzumab. A baseline echocardiogram showed an LVEF of 0.59 and, on STE analysis, a GLS of −19%. Three months later, the patient's LVEF was unchanged, but her GLS had decreased to −15.2% (Fig. 8). Then, 3 months after that, a follow-up echocardiogram showed an LVEF of 0.44.
The polar map at 3-month follow-up revealed somewhat patchy but almost global depression in strain percentages with normal LVEF. This first sign of myocardial dysfunction was seen 3 months before the dysfunction became evident by conventional LVEF measurement.
Stress-Induced Cardiomyopathy. A 77-year-old man with a history of pancreatic cancer metastatic to the liver, dyslipidemia, cerebrovascular accident, left-lower-extremity deep vein thrombosis, and gastrointestinal bleeding was admitted for fever and abdominal pain. Results of radiologic studies done on arrival showed biliary obstruction, leading to cholangitis and possible mesenteric ischemia with progression of the metastatic pancreatic cancer. An abdominal left external biliary drain was placed soon after admission, and sepsis secondary to ascending cholangitis was found. Cardiac enzyme levels were mildly elevated. An ECG showed sinus rhythm, moderate intraventricular conduction delay, ST-segment deviation, and moderate T-wave abnormality in the anterolateral leads. An echocardiogram revealed an LVEF of 0.40 to 0.45 and a wall-motion pattern consistent with stress-induced (takotsubo) cardiomyopathy, or apical ballooning syndrome.
In this case, the polar map pattern was the reverse of that seen for apical preservation in classic amyloidosis (Fig. 9). The blue-to-pink distribution in the mid-to-apical segments correlated with the apical ballooning. The dark red in the basal segments correlated with preserved basal myocardial function.
Suspected Infiltrative Process, Increased Left Ventricular Mass. A 52-year-old woman presented for evaluation of abnormal echocardiographic findings. Her medical history included hypertension, low-grade B-cell lymphoma with plasmacytic differentiation treated by autologous stem cell transplantation, amyloid deposition, rheumatoid arthritis, Sjögren disease, thymoma treated by resection, and Waldenström macroglobulinemia. A progressive increase in LV mass had been noted on echocardiograms over the previous 7 months. The most recent echocardiogram appeared to show an infiltrative or increased mass of the LV.
The patient's polar map revealed an intense red pattern with the highest deformation values in the apical segments, indicating apical preservation (Fig. 10). An endomyocardial biopsy was negative for amyloid on 2 separate occasions 2 years apart.
Amyloidosis. A 53-year-old man with a medical history of hypertension, dyslipidemia, atrial fibrillation, multiple myeloma treated by autologous stem cell transplantation, and cardiac amyloidosis presented with lower-extremity edema. He reported no chest pain, shortness of breath, paroxysmal nocturnal dyspnea, or orthopnea. An ECG showed low voltage. An echocardiogram showed an LVEF of 0.40 and, on STE analysis, a strain pattern indicative of amyloidosis. Of note, previous left-sided heart catheterization had revealed normal coronary arteries.
This patient's polar map revealed the classic bull's-eye pattern seen in cardiac amyloidosis (Fig. 11). The dark red at the apex and the surrounding pink-to-blue distribution indicated apical preservation.
Incorporating strain analysis into echocardiography has provided substantial diagnostic and prognostic benefit to the field of cardio-oncology. Myocardial deformation assessment by STE, an angle-independent method, can enable detection of subclinical LV dysfunction before it is perceptible by conventional echocardiography. Because STE is nontoxic and entails no exposure to ionizing radiation, it should be considered the cardiac imaging method of choice in most centers. However, it has certain limitations. Speckle tracking–derived strain is profoundly dependent on image quality throughout the cardiac cycle. In addition, the different strain patterns described in the case reports presented here are not entirely specific for any given cardiovascular condition. Thus, STE cannot be used to establish a cause of disease without clinical correlation. Further research to better understand the full potential of myocardial strain imaging by STE and its interpretation in cardio-oncologic care is warranted.
The authors thank Chloe C. French for proofreading this article and Ms Huyen Tran for image formatting.